Publication | Closed Access

Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibition

Metastatic Breast CancerEngineeringBreast OncologyCyclin-dependent Kinase InhibitionOncologic ImagingBreast ImagingBreast CancerRadiation OncologyOncologyMolecular ImagingNuclear MedicineEndocrine-related CancerRadiologyHealth Sciences